Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Cataracts
Interventions
DEVICE

Lens implantation +1.00 D postop target

Lens implantation +1.00 D postoperative MRSE target. Light Delivery Device treatment based on postoperative manifest refraction.

DEVICE

Lens implantation -1.00 D postop target

Lens implantation -1.00 D postoperative MRSE target. Light Delivery Device treatment based on postoperative manifest refraction.

DEVICE

Lens implantation 0.00 D postop target

Lens implantation 0.00 D postoperative MRSE target. Light Delivery Device treatment based on postoperative manifest refraction.

Trial Locations (6)

22320

CODET Vision Institute, Tijuana

46260

Price Vision Group, Indianapolis

63017

Pepose Vision Institute, Chesterfield

66211

Discover Vision Centers, Leawood

90024

Maloney Vision Institute, Los Angeles

94024

Altos Eye Physicians, Los Altos

Sponsors
All Listed Sponsors
lead

Calhoun Vision, Inc.

INDUSTRY